Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study

BACKGROUND: Dystrophic epidermolysis bullosa (EB) is a family of rare genetic dermatological conditions. Recent evidence indicated that in addition to its detrimental implications on patient health-related quality of life (HRQoL), there are substantial socioeconomic cost implications, especially reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelis, A., Mellerio, J. E., Kanavos, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450448/
https://www.ncbi.nlm.nih.gov/pubmed/36068590
http://dx.doi.org/10.1186/s13023-022-02419-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450448/
https://www.ncbi.nlm.nih.gov/pubmed/36068590
http://dx.doi.org/10.1186/s13023-022-02419-1

Ejemplares similares